Latest News & Updates

Breaking News

  • 21 minutes ago

  • Simantini Singh Deo

Catalyst Pharmaceuticals Earns No. 11 Spot On Forbes’ 2026 Small-Cap Success List, Recognized For Strong Growth And Rare-Disease Focus
Breaking News
Revolution Medicines Receives FDA Breakthrough Therapy Designation For Zoldonrasib, Advancing Targeted Cancer Treatment

Simantini Singh Deo

Other trending news you may like to read

Catalyst Pharmaceuticals Earns No. 11 Spot On Forbes’ 2026 Small-Cap Success List, Recognized For Strong Growth And Rare-Disease Focus

Catalyst Pharmaceuticals secures the 11th spot on Forbes’ 2026 America’s Most Successful Small-Cap Companies list.

Simantini Singh Deo

Pharma Now

Revolution Medicines Receives FDA Breakthrough Therapy Designation For Zoldonrasib, Advancing Targeted Cancer Treatment

Revolution Medicines’ zoldonrasib receives FDA Breakthrough designation for KRAS G12D-mutated advanced NSCLC.

Simantini Singh Deo

Pharma Now

MUSC Health And Baxter Form Strategic Partnership To Advance Connected Care And Nursing Innovation

MUSC Health and Baxter form a strategic partnership to improve nursing efficiency, care quality, and connected healthcare delivery.

Vaibhavi M.

Pharma Now

Ascendis Pharma Reports Positive Week 52 Phase 2 COACH Trial Results For TransCon CNP And hGH In Achondroplasia

Ascendis shows durable growth, improved body proportionality, and favorable safety with TransCon CNP plus TransCon hGH in achondroplasia.

Vaibhavi M.

Pharma Now